Veterinary laboratory testing market is expected grow USD 34.80 Billion at a CAGR 11.3% during the forecast period.
Veterinary Laboratory Testing Market Overview:
The veterinary laboratory testing market is expected to rise at a CAGR of 10.1%, with a value of USD 2200 million over the estimated forecast year of 2020-2027.
Veterinary healthcare refers to a subset of science that deals with diagnosing, treating, and preventing various diseases in animals to expand their lifespan. It involves several services, including regular monitoring of animal health and deployment of medicated animal feeds, diagnostic products, drugs, and vaccines for limiting the spread of zoonotic diseases among animals and people. These amenities are extensively provided by the sole traders, pharmacies, veterinary hospitals, clinics, and laboratory testing services. Veterinary healthcare facilities are available for both companions and livestock animals.
The global veterinary healthcare market is driven by the increasing prevalence of various zoonotic, food-borne, and chronic diseases, such as cancer, especially among cats and dogs. This is further supported by the emerging trend of pet humanization and the increasing concerns of pet owners toward animal health, which, in turn, is facilitating the demand for preventive and more sophisticated veterinary services and therapeutic and diagnostics treatments. In line with this, significant technological advancements, such as introducing veterinary health information systems for efficient data management, are another growth-inducing factor. These devices assist in diagnosing animal health, facilitating real-time analysis of disease fluctuations, recording information on cloud-based platforms, and sharing essential veterinary clinic-generated data with clinicians and researchers directly through the internet.
The veterinary laboratory testing market has been segmented into animal type, technology, product, and end user.
The market, on the basis of animal type, has been segmented into companion animal and livestock animal. The companion animal segment is further classified as dogs, cats, horses and others. The livestock animal segment is further classified as cattle, pigs, poultry and others.
The market, by technology, has been segmented into clinical biochemistry, immunodiagnostics, hematology, molecular diagnostics, urinalysis, and others.
The clinical biochemistry segment is further classified as clinical chemistry analysis, glucose monitoring, and blood gas & electrolyte analysis. The clinical chemistry analysis segment includes clinical chemistry reagent clips and cartridges and clinical chemistry analyzers. The glucose monitoring segment includes blood glucose strips, glucose monitors and urine glucose strips. The blood gas & electrolyte analysis segment includes blood gas and electrolyte reagent clips and cartridges and blood gas & electrolyte analyzers.
The immunodiagnostics segment is further classified as ELISA tests, lateral flow assays, allergen-specific immunodiagnostic tests, immunoassay analyzers, and others. The lateral flow assays segment includes lateral flow rapid tests, and lateral flow strip readers.
The hematology segment is further classified as hematology cartridges, and hematology analyzers.
The molecular diagnostics segment is further classified as polymerase chain reaction (PCR) tests, microarrays, and others.
The urinalysis segment is further classified as urinalysis clips & cartridges/panels, urine analyzers, and urine test strips.
The market, by product, has been segmented into consumables and instruments.
The market, by end user, has been segmented into veterinary hospitals & clinics, in-house testing, research institutes, diagnostic laboratories, and others. The veterinary hospitals & clinics segment held the largest segment of the market in 2017. This can be attributed to the increasing incidence of zoonotic diseases. On the other hand, the academic institutes segment is estimated to be the fastest growing segment.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The veterinary laboratory testing market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European veterinary laboratory testing market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The veterinary laboratory testing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The veterinary laboratory testing market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Veterinary Laboratory Testing Market Share (%), by Region, 2017
Source: Centers for Disease Control and Prevention (CDC), Eurostat, White Papers, Company Presentations, Annual Reports
Geographically, the Americas is anticipated to dominate the veterinary laboratory testing market owing to increasing cases of animal disease and technological advancements in veterinary diagnostics.
For instance, in 2016, IDEXX Laboratories, Inc. launched the Rapid Visual Pregnancy Test for cattle. With the new test, veterinarians can more quickly identify open cows using whole blood samples collected before the farm visit.
Europe is expected to hold the second largest position in the veterinary laboratory testing market. The market growth in this region is attributed to the rising expenditure on pet insurance.
The Veterinary Laboratory Testing Market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the awareness regarding use of sterile consumables for lab testing and rising healthcare spending.
The Middle East & Africa contributes least in the global market for veterinary laboratory testing.
Veterinary Laboratory Testing Market, by Animal Type
Veterinary Laboratory Testing Market, by Technology
Veterinary Laboratory Testing Market, by Product
Veterinary Laboratory Testing Market, by End User
Veterinary Laboratory Testing Market, by Region
Veterinary Laboratory Testing Market, by Key Players
In May 2020, the United States Department of Agriculture’s (USDA) National Veterinary Services Laboratories confirmed SARS-CoV-2 in one tiger at a zoo in New York. As per the World Organization for Animal Health, as of 2020, there are approximately 117 animal diseases, infections, and infestations. In addition, with the rising pet ownership and increasing awareness, the veterinary diagnostics market is expected to grow over the forecast period.Intended Audience
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Animal type, Technology, Product, and End user|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Abaxis Inc., BIOCHECK Inc., Biomérieux SA, Henry Schein Inc., Heska Corporation, Idexx Laboratories, Idvet, Neogen Corporation, Pfizer, Qiagen N.V., Randox Laboratories Ltd., Thermo Fisher Scientific, VCA Inc., Virbac, Zoetis Inc.|
|Key Market Opportunities||Rising incidence of zoonotic diseases|
|Key Market Drivers||
The veterinary laboratory testing market was valued at USD 2,200 million in 2017.
The veterinary laboratory testing market is expected to exhibit a solid 10.1% CAGR over the forecast period from 2018 to 2023.
The growing prevalence of zoonotic diseases is the major driver for the veterinary laboratory testing market.
The Americas market holds the largest share in the global veterinary laboratory testing market, followed by Europe, due to the widespread awareness about veterinary diseases and laboratory testing.
Leading players in the veterinary laboratory testing market include Abaxis Inc., Henry Schein Inc., Heska Corporation, Idvet, Neogen Corporation, and Pfizer, among others.